I thank Mr. McGovern for yielding me the customary 30 minutes, and I yield myself such time as I may consume. Mr. Speaker, today, we consider a resolution to once again assert the position of the House of Representatives with respect to the Armenian genocide that occurred between 1915 and 1923. This resolution cites previous United States recognition of the killing of Armenians, including in 1951, 1975, 1981, and 1984. Numerous resolutions have been introduced in the House and Senate that did not pass both Chambers. In addition, Congress has twice designated April 24 as a National Day of Remembrance of Man's Inhumanity to Man, specifically referencing Armenia. The United States has clearly indicated its support to the Armenians. While there is historic precedent for recognizing the Armenian genocide, passing such a resolution today could complicate the situation with a NATO ally. Previously, this has resulted in protests at and around the Incirlik Air Base that have affected our men and women in uniform who were stationed there. While the desire to recognize the Armenian genocide is laudable, these events took place over 100 years ago. It remains unclear why we are urgently considering this resolution. The Committee on Foreign Affairs did not conduct a hearing or hold a markup before we voted last night in the Rules Committee to bring this to the floor today.…
Share
More from Michael Burgess
I thank the Representative from New York for yielding me the time. Mr. Speaker, I rise in support of the rule. I rise in support of the underlying bills, in particular, H.R. 9494 to provide continuing funding for the Government of the…
I thank my friend from New York for yielding, and I thank him for leading this discussion on behalf of the Rules Committee today. I wanted to come down and speak in support of the rule, and I want to speak in support of the underlying…
I led a letter to the FDA asking them to reclassify naloxone to where you could get it without a prescription.
I thank Dr. Bucshon from Indiana for yielding me the time on such an important reauthorization that we are undertaking today. Mr. Speaker, 2018 was the last authorization for sickle cell research. Prior to that, it had been part of the…





